Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded
- Contract number
- SPE2DR26F5N19
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,565
Award facts
- Contract value 100% obligated
- $10,565.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes with a ceiling value of $10,565.09. This delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, operates under firm fixed-price terms with no set-aside designation. The award is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Dupixent (dupilumab) is a prescription medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic conditions, making this delivery consistent with the contractor's portfolio of specialty medications supporting Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5N19?
SPE2DR26F5N19 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F5N19 worth?
The government has obligated $10,565 on SPE2DR26F5N19.
Is contract SPE2DR26F5N19 an order under another contract?
Yes. SPE2DR26F5N19 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5N19 competed?
The extent of competition for SPE2DR26F5N19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award